Everything you need to know about bird flu
A dangerous bird flu, in other words, was suddenly circulating in mammals—mammals with which people have ongoing, extensive ...
What is Zacks Small Cap’s Estimate for COCP Q1 Earnings?
Stock analysts at Zacks Small Cap issued their Q1 2025 earnings per share (EPS) estimates for Cocrystal Pharma in a research ...
Cocrystal Pharma Reports 2024 Financial Results and Provides Updates on its Antiviral Drug-Development Programs
Cocrystal Pharma, Inc. is a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, coronaviruses ...
A hidden strategy: How SARS-CoV-2 uses fibrinogen to evade the immune system
As scientists, we often think we understand a virus—its structure, its tricks, the way it moves through the body. But every ...
Analysts Offer Predictions for COCP Q3 Earnings
Equities research analysts at Zacks Small Cap issued their Q3 2025 earnings per share (EPS) estimates for Cocrystal Pharma in a research report issued to clients and investors on Tuesday, April 1st.
New COVID-19 drug shows greater promise against resistant viral strains
Rutgers Health researchers have developed an oral antiviral drug candidate for COVID-19 that could overcome major limitations ...
The StarPhoenix2d
Photos: University of Saskatchewan's 2025 Images of Research contest winners
The 2025 U of S Images of Research photo and imaging competition celebrates the beauty and artistry in the work of University ...